Stocknear Logo Stocknear
/
Popular
Login

Denali Therapeutics Inc.

15.68
0.19 (1.23%)
At close: Apr 25, 2025, 3:09 PM

Denali Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Revenue peaked at - in undefined and hit its lowest at - in undefined. Over the past five years, it has declined by undefined%.

undefined

n/a
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
-422.77M -145.22M -325.99M -290.58M 71.14M -197.61M -36.24M -88.19M -86.65M
8.99M 16.73M 10.38M 8.59M 8.53M 7.99M 7.42M 3.08M 1.47M
102.88M 108.1M 99.85M 85.25M 50.35M 38.38M 18.79M 4.41M 2.95M
15.5M -292.36M -26.3M -24.12M 290.02M 3.14M 63.42M 3.1M 4.13M
-53.73M -47.67M -4.92M -2.98M -2.32M 513K -2.74M 754K 5.28M
n/a n/a n/a 8.75M 55K -5.02M n/a n/a 307K
16.94M -289.93M -24.03M -20.41M 288.4M 4.17M 62.89M 3.31M 4.29M
-347.69M -357.99M -244.72M -211.39M 416.15M -151.58M 50.12M -76.64M -72.36M
-15.91M -12.94M -17.83M -8.5M -3.1M -17.92M -3.39M -2.88M -6.13M
n/a n/a 123.55M 13.13M 620.11M -165.63M n/a n/a n/a
-1.23B -1.81B -1.12B -1.42B -1.29B -369.7M -557.93M -179.79M -226.87M
1.16B 2.08B 991.49M 1.41B 665.36M 535.33M 273.9M 141.5M 14M
n/a n/a -123.55M -13.13M -620.11M 165.63M -284.03M -38.29M -212.87M
-88.76M 249.31M -141.39M -21.63M -623.21M 147.71M -287.42M -41.17M -219M
-32.34M n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
17.39M 17.82M 14.46M 19.35M 20.66M 6.19M 2.61M 733K 111K
484.3M 17.82M 310.67M 19.35M 634.75M 6.19M 97.02M 296.32M 300.48M
47.85M -90.86M -75.43M -213.67M 427.69M 2.33M -140.29M 178.52M 9.11M
-363.61M -370.93M -262.55M -219.89M 413.06M -169.5M 46.72M -79.51M -78.49M

Create Price Alert on DNLI

Your price alert will notify you when the stock price is above 15.68.

Add to Watchlist